Call For More Information (410) Skype715-2111
Blog: Recent Posts
  1. Advancements in Prenatal Genetic Tests – Noninvasive

    New prenatal genetic tests hold promise, worries By Carolyn Y. Johnson SWANSEA — On a stormy Valentine’s Day in 2007, Courtney Kane felt herself detach from her body and float up to the ceiling. She watched as the figure below, 19 weeks pregnant, reclined on a bed in an exam...
  2. Society’s Distorted Views on Downs Syndrome

    Deciding Not to Screen for Down Syndrome By LISA BELKIN Amy Julia Becker is expecting her third child in January. She is 32 years old, and her age, plus the fact that her first child was born with Down syndrome, magnifies her odds of a chromosomal abnormality in this pregnancy, leading...

Prenatal Genetic Testing

Ravgen was founded with the goal of developing fetal DNA sequencing methods for patients seeking a prenatal test which is both safe during pregnancy and highly accurate. The key to developing this technology lies in Ravgen’s ability to increase the percentage of fetal DNA present in blood from the pregnant mother. Increasing the percentage of fetal DNA in a tube of blood from the mother is the first step towards the development of noninvasive prenatal diagnostic testing for many genetic disorders such as Downs syndrome. Current applications for noninvasive prenatal testing include single gene disorders such as cystic fibrosis, sickle cell anemia, the Eastern European Jewish panel, and paternity testing.

Please visit the specific page for each noninvasive prenatal test to learn more about our research and testing. Ravgen welcomes inquiries regarding prenatal tests which are not seen here as our laboratory is continuously moving forward in this field.